Company profile: BioAgilytix
1.1 - Company Overview
Company description
- Provider of bioanalytical lab services specializing in immunoassays and cell-based assays, based in Research Triangle Park, NC. Offers custom assay development (de novo, partial, cross-matrix, GxP validations), method transfer, preclinical and clinical sample analysis, specimen collection kit support, off-the-shelf assays, and biomedical diagnostic testing for infectious diseases, diagnostic immunology, vitamin and parasite-borne infections, and LDTs.
Products and services
- Custom Assay Development: BioAgilytix architects GxP-compliant custom assay development tailored to bioanalytical needs, delivering de novo development, partial validations, and cross-matrix validations for immunoassays and cell-based assays
- Sample Analysis: BioAgilytix delivers preclinical/clinical-stage, on-time, accurate, high-quality sample analysis for immunoassays and cell-based assays, producing reliable results during drug development and clinical testing
- Method Transfer: BioAgilytix supplies cross-vendor method transfer to ensure reproducible assay performance during drug development, transferring assays from sponsors and other vendors while maintaining consistency
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioAgilytix
Phlow
HQ: United States
Website
- Description: Provider of affordable, quality essential medicines using U.S.-based advanced manufacturing processes. Helps ensure the quality, safety, and affordability of pharmaceutical products of strategic importance to the United States, leveraging advanced manufacturing platforms, including continuous manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phlow company profile →
Food and Drug Analytical Services
HQ: United Kingdom
Website
- Description: Provider of independent pharmaceutical quality control testing, delivering full contract testing services incorporating chemistry, microbiology, stability, and development capabilities to some of the UK's largest pharmaceutical companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Food and Drug Analytical Services company profile →
Pharmaceutics International
HQ: United States
Website
- Description: Provider of science-driven contract development and manufacturing services, offering formulation development and clinical trial manufacturing for drugs and biologics; solubility/bioavailability enhancement; lyophilization formulation and cycle development with GMP scale-up; fill-finish development and aseptic fill-finish for vials, syringes, and cartridges; and ready-to-use 3mL cartridges for consistent delivery of high-viscosity, high concentration injectables.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharmaceutics International company profile →
Certis Oncology
HQ: United States
Website
- Description: Provider of precision oncology and translational science solutions, including Certis Oncology Intelligence® for predictive therapeutic response data from advanced cancer models with AI-driven bioinformatics; BarneyOI® cancer model database; CertisAI™ drug response prediction; O-PDX models; 3D cell cultures; and custom in vitro pharmacology and ex vivo assays, including cell line development, to help bridge the preclinical–clinical translation gap.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Certis Oncology company profile →
LakePharma
HQ: United States
Website
- Description: Provider of integrated biologics CRDMO services from discovery and engineering to development and GMP manufacturing. Offerings include antibody discovery and engineering, protein engineering and production, cell line development, phage and yeast display, hybridoma technologies, viral vector platforms (Baculovirus, AAV, Lentivirus), plasmid DNA services, and ISO 13485:2016 GMP manufacturing of mRNA, antibodies, proteins, and vaccines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LakePharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioAgilytix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioAgilytix
2.2 - Growth funds investing in similar companies to BioAgilytix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioAgilytix
4.2 - Public trading comparable groups for BioAgilytix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →